Raymond James Financial’s Prestige Consumer Healthcare PBH Stock Holding History

Raymond James Financial’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.9M	Sell	464,353 -92,107	-17%	-$4.73M	0.01%	1492
2026 Q1	$32.7M	Sell	556,460 -54,291	-9%	-$3.52M	0.01%	1132
2025 Q4	$37.9M	Sell	610,751 -27,181	-4%	-$1.66M	0.01%	999
2025 Q3	$39.8M	Buy	637,932 +86,373	+16%	+$6.01M	0.01%	946
2025 Q2	$44M	Sell	551,559 -16,619	-3%	-$1.39M	0.02%	837
2025 Q1	$48.8M	Buy	568,178 +22,738	+4%	+$1.87M	0.02%	734
2024 Q4	$42.6M	Buy	+545,440	New	+$42.3M	0.02%	814

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's PBH Position: Q2 2026 in Review

Raymond James Financial reduced its Prestige Consumer Healthcare (PBH) stake by 17% in Q2 2026, selling an estimated $4.73M and leaving 464,353 shares worth $21.9M. The position accounts for 0.01% of the portfolio, ranked #1492.

Raymond James Financial first reported a position in PBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $48.8M in Q1 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Raymond James Financial held 464,353 shares of Prestige Consumer Healthcare worth $21.9M as of Q2 2026.
Raymond James Financial sold 92,107 Prestige Consumer Healthcare shares in Q2 2026, an estimated $4.73M.
Prestige Consumer Healthcare made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1492 holding.
Raymond James Financial first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's Prestige Consumer Healthcare position peaked at $48.8M in Q1 2025.
320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.